Genetic and Clinical Correlates of Early-Outgrowth Colony-Forming Units

Background— Several bone marrow–derived cell populations may have angiogenic activity, including cells termed endothelial progenitor cells. Decreased numbers of circulating angiogenic cell populations have been associated with increased cardiovascular risk. However, few data exist from large, unselected samples, and the genetic determinants of these traits are unclear. Methods and Results— We examined the clinical and genetic correlates of early-outgrowth colony-forming units (CFUs) in 1799 participants of the Framingham Heart Study (mean age, 66 years; 54% women). Among individuals without cardiovascular disease (n=1612), CFU number was inversely related to advanced age (P=0.004), female sex (P=0.04), and triglycerides (P=0.008) and positively related to hormone replacement (P=0.008) and statin therapy (P=0.027) in stepwise multivariable analyses. Overall, CFU number was inversely related to the Framingham risk score (P=0.01) but not with prevalent cardiovascular disease. In genome-wide association analyses in the entire sample, polymorphisms were associated with CFUs at the MOSC1 locus (P=3.3×10−7) and at the SLC22A3-LPAL2-LPA locus (P=4.9×10−7), a previously replicated susceptibility locus for myocardial infarction. Furthermore, alleles at the SLC22A3-LPAL2-LPA locus that were associated with decreased CFUs were also related to increased risk of myocardial infarction (P=1.1×10−4). Conclusions— In a community-based sample, early-outgrowth CFUs are inversely associated with select cardiovascular risk factors. Furthermore, genetic variants at the SLC22A3-LPAL2-LPA locus are associated with both decreased CFUs and an increased risk of myocardial infarction. These findings are consistent with the hypothesis that decreased circulating angiogenic cell populations promote susceptibility to myocardial infarction.

[1]  Arjun Deb,et al.  Hard luck stories: the reality of endothelial progenitor cells continues to fall short of the promise. , 2010, Circulation.

[2]  E. Falk,et al.  Circulating Endothelial Progenitor Cells Do Not Contribute to Plaque Endothelium in Murine Atherosclerosis , 2010, Circulation.

[3]  Stephen Kaptoge,et al.  Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. , 2009, JAMA.

[4]  Qingbo Xu,et al.  Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures. , 2009, Blood.

[5]  M. Yoder.  Platelet MPs obscure some EPC definitions. , 2009, Blood.

[6]  Børge G Nordestgaard,et al.  Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. , 2009, JAMA.

[7]  B. Herbert,et al.  Premature senescence of highly proliferative endothelial progenitor cells is induced by tumor necrosis factor‐α via the p38 mitogen‐activated protein kinase pathway , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  Benjamin J. Wright,et al.  Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease , 2009, Nature Genetics.

[9]  A. Sirker,et al.  Vascular progenitor cells and translational research: the role of endothelial and smooth muscle progenitor cells in endogenous arterial remodelling in the adult. , 2009, Clinical science.

[10]  Patrick F. Sullivan,et al.  A framework for interpreting genome-wide association studies of psychiatric disorders , 2009, Molecular Psychiatry.

[11]  J. P. McCoy,et al.  Microarray-Based Characterization of a Colony Assay Used to Investigate Endothelial Progenitor Cells and Relevance to Endothelial Function in Humans , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[12]  J. Rumberger,et al.  Circulating CD34+ Cell Count is Associated with Extent of Subclinical Atherosclerosis in Asymptomatic Amish Men, Independent of 10-Year Framingham Risk , 2009, Clinical medicine. Cardiology.

[13]  F. Timmermans,et al.  Endothelial progenitor cells: identity defined? , 2008, Journal of cellular and molecular medicine.

[14]  C. DeSouza,et al.  Aging and endothelial progenitor cell telomere length in healthy men , 2009, Clinical chemistry and laboratory medicine.

[15]  R. Collins,et al.  Common variants at 30 loci contribute to polygenic dyslipidemia , 2009, Nature Genetics.

[16]  Qingbo Xu,et al.  SDF1 Gene Variation Is Associated with Circulating SDF1α Level and Endothelial Progenitor Cell Number–The Bruneck Study , 2008, PloS one.

[17]  K. Hirschi,et al.  Assessing identity, phenotype, and fate of endothelial progenitor cells. , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[18]  A. Avogaro,et al.  Gender Differences in Endothelial Progenitor Cells and Cardiovascular Risk Profile: The Role of Female Estrogens , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[19]  K. Mossman.  The Wellcome Trust Case Control Consortium, U.K. , 2008 .

[20]  Qingbo Xu,et al.  Endothelial Progenitor Cells, Cardiovascular Risk Factors, Cytokine Levels and Atherosclerosis – Results from a Large Population-Based Study , 2007, PloS one.

[21]  A. Avogaro,et al.  Endothelial progenitor cells in the natural history of atherosclerosis. , 2007, Atherosclerosis.

[22]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[23]  A. Shah,et al.  Vascular Dysfunction and Reduced Circulating Endothelial Progenitor Cells in Young Healthy UK South Asian Men , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[24]  Tatiana A. Tatusova,et al.  Entrez Gene: gene-centered information at NCBI , 2004, Nucleic Acids Res..

[25]  Greta L. Hoetzer,et al.  Gender differences in circulating endothelial progenitor cell colony-forming capacity and migratory activity in middle-aged adults. , 2007, The American journal of cardiology.

[26]  H. Zhang,et al.  Adult endothelial progenitor cells from human peripheral blood maintain monocyte/macrophage function throughout in vitro culture , 2006, Cell Research.

[27]  Z. Yang,et al.  Circulating endothelial progenitor cell deficiency contributes to impaired arterial elasticity in persons of advancing age , 2006, Journal of Human Hypertension.

[28]  Terence P. Speed,et al.  Genome analysis A genotype calling algorithm for affymetrix SNP arrays , 2005 .

[29]  G. Nickenig,et al.  Circulating endothelial progenitor cells and cardiovascular outcomes. , 2005, The New England journal of medicine.

[30]  S. Fichtlscherer,et al.  Reduced Number of Circulating Endothelial Progenitor Cells Predicts Future Cardiovascular Events: Proof of Concept for the Clinical Importance of Endogenous Vascular Repair , 2005, Circulation.

[31]  M. Kelm,et al.  Impaired progenitor cell activity in age-related endothelial dysfunction. , 2005, Journal of the American College of Cardiology.

[32]  H. Kubo,et al.  Increased circulating endothelial progenitor cells in patients with bacterial pneumonia: evidence that bone marrow derived cells contribute to lung repair , 2005, Thorax.

[33]  Alexandra Paillusson,et al.  A GFP-based reporter system to monitor nonsense-mediated mRNA decay , 2005, Nucleic acids research.

[34]  L. Tavazzi,et al.  Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. , 2005, Blood.

[35]  M. Gnecchi,et al.  Cytokine-Induced Mobilization of Circulating Endothelial Progenitor Cells Enhances Repair of Injured Arteries , 2004, Circulation.

[36]  H. Drexler,et al.  Statin-Induced Improvement of Endothelial Progenitor Cell Mobilization, Myocardial Neovascularization, Left Ventricular Function, and Survival After Experimental Myocardial Infarction Requires Endothelial Nitric Oxide Synthase , 2004, Circulation.

[37]  S. Dimmeler,et al.  Endothelial Progenitor Cells: Characterization and Role in Vascular Biology , 2004, Circulation research.

[38]  A. Zeiher,et al.  Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis? , 2004, Journal of Molecular Medicine.

[39]  O. Kuss,et al.  Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. , 2004, Journal of the American College of Cardiology.

[40]  J. Isner,et al.  Estrogen-Mediated, Endothelial Nitric Oxide Synthase–Dependent Mobilization of Bone Marrow–Derived Endothelial Progenitor Cells Contributes to Reendothelialization After Arterial Injury , 2003, Circulation.

[41]  O. Kuss,et al.  Age-dependent depression in circulating endothelial progenitor cells inpatients undergoing coronary artery bypass grafting , 2003 .

[42]  A. Quyyumi,et al.  Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. , 2003, The New England journal of medicine.

[43]  U. Dirnagl,et al.  Estrogen Increases Bone Marrow‐Derived Endothelial Progenitor Cell Production and Diminishes Neointima Formation , 2003, Circulation.

[44]  W. Hofmann,et al.  HMG-CoA Reductase Inhibitors Reduce Senescence and Increase Proliferation of Endothelial Progenitor Cells via Regulation of Cell Cycle Regulatory Genes , 2003, Circulation research.

[45]  Christie M. Orschell,et al.  Peripheral Blood “Endothelial Progenitor Cells” Are Derived From Monocyte/Macrophages and Secrete Angiogenic Growth Factors , 2003, Circulation.

[46]  P. Libby.  Inflammation in atherosclerosis , 2002, Nature.

[47]  S. Fichtlscherer,et al.  Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery Disease , 2001, Circulation research.

[48]  S. Homma,et al.  Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function , 2001, Nature Medicine.

[49]  J. Isner,et al.  Therapeutic Potential of Ex Vivo Expanded Endothelial Progenitor Cells for Myocardial Ischemia , 2001, Circulation.

[50]  L. Almasy,et al.  Multipoint quantitative-trait linkage analysis in general pedigrees. , 1998, American journal of human genetics.

[51]  D. Levy,et al.  Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.

[52]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[53]  W. Kannel,et al.  An investigation of coronary heart disease in families. The Framingham offspring study. , 1979, American journal of epidemiology.

[54]  T. Dawber,et al.  Epidemiological approaches to heart disease: the Framingham Study. , 1951, American journal of public health and the nation's health.